US OptionsDetailed Quotes
PFE240712P39000
- 10.90
- 0.000.00%
15min DelayClose Jul 12 15:59 ET
0.00High0.00Low
10.90Open10.90Pre Close0 Volume0 Open Interest39.00Strike Price0.00Turnover0.00%IV2.84%PremiumJul 12, 2024Expiry Date10.08Intrinsic Value100Multiplier-1DDays to Expiry0.82Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.88Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Pfizer Stock Discussion
The P2 data they published in obese, non-diabetics doesn't look too good. Danuglipron twice daily compared with $Eli Lilly and Co(LLY.US)$ Orforglipron and $Structure Therapeutics(GPCR.US)$ GSBR 1290 at week 12: Orforglipron seems to be the best non-peptide GLP-1 RA
AI stocks may be struggling in short term but fundamentals are still very strong. A little pullback is normal.
loading...
Gapping up
$Costco(COST.US)$ shares saw an increase of nearly 1.34% as the company announced its first membership fee increase since 2017, raising the cost of its annual membership in the U.S. and Canada by $5 and its higher-tier plan by $10.
$Pfizer(PFE.US)$ 's stock went up nearly 2.8% following the company's announcement that it will proceed with the development of a once-daily version of its weight loss pill, ...
According to Zhittong Finance, Pfizer announced on Tuesday that Mikael Dolsten, its Chief Scientific Officer and R&D President, will leave the company after more than 15 years of service. The New York-based pharmaceutical giant said it would launch a months-long external recruitment program to identify a new Chief Scientific Officer, a move expected to last until early next year. The company said, "Dolsten will assist in job search and continue in his current role until his s...
Gapping up
$Amazon(AMZN.US)$ stock increased by 0.13% after the company unveiled a new $79 Echo Spot alarm clock featuring a refreshed design and enhanced audio quality.
$Intel(INTC.US)$ stock leapt 2.68% following a previous session gain of over 6%, with Nvidia also up 1.57% and Marvell rising by 0.69%, as AI-associated stocks continued to gain favor.
$Pfizer(PFE.US)$ stock inched up by 0.18% on the news that i...
No comment yet